Biobank For MS And Other Demyelinating Diseases

Active, not recruitingOBSERVATIONAL
Enrollment

3,226

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2030

Study Completion Date

October 31, 2036

Conditions
Multiple SclerosisTransverse MyelitisNeuromyelitis OpticaAcute Disseminated EncephalomyelitisOptic Neuritis
Trial Locations (10)

10019

Multiple Sclerosis Research Center of New York, New York

21287

Johns Hopkins, Baltimore

30309

Shepherd Center, Atlanta

43210

The Ohio State University, Columbus

76051

University of Texas Southwestern Medical Center at Dallas, Dallas

80045

The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver, Aurora

85013

Barrow Neurological Institute, Phoenix

94305

Stanford University, Stanford

02215

Beth Israel Deaconess, Boston

01605

University of Massachusetts Medical School, Worcester

All Listed Sponsors
lead

Accelerated Cure Project for Multiple Sclerosis

OTHER

NCT00445367 - Biobank For MS And Other Demyelinating Diseases | Biotech Hunter | Biotech Hunter